dihydroergotamine has been researched along with yohimbine in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (55.17) | 18.7374 |
| 1990's | 9 (31.03) | 18.2507 |
| 2000's | 2 (6.90) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamblin, MW; Metcalf, MA | 1 |
| Batink, H; de Jonge, A; Thoolen, MJ; Timmermans, PB; van Zwieten, PA; Wilffert, B | 1 |
| Adham, N; Bard, JA; Branchek, TA; Vaysse, P; Weinshank, RL; Zgombick, J | 1 |
| Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hoffmann, J | 1 |
| Wampola, H | 1 |
| Goebel, KM; Neitzert, A | 1 |
| Winkler, A | 1 |
| Schulte, B | 1 |
| Reuse-Blom, S | 1 |
| Fontela, T; García Hermida, O; Gómez-Acebo, J | 1 |
| Müller-Schweinitzer, E | 2 |
| Müller-Schweinitzer, E; Rosenthaler, J | 2 |
| Ekström, J; Månsson, B; Nilsson, BO; Rosengren, E; Tobin, G | 1 |
| Heidrich, H | 1 |
| Dietzel, M; Grünberger, J; Lesch, OM; Musalek, M; Saletu, B; Schjerve, M; Walter, H; Werner, U; Zeiler, K | 1 |
| Markwardt, F; Nowak, G | 1 |
| Kato, R; Nakadate, T; Nakaki, T | 1 |
| Cavalca, L; Ghirardi, P; Ligresti, A; Marchetti, G; Marzo, A; Merlo, L; Omboni, E; Parenti, MA; Pignataro, T | 1 |
| Schirger, A; Schwartz, GL | 1 |
| Morris, JL | 1 |
| Glusa, E; Roos, A | 1 |
| Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM | 1 |
| Centurión, D; Cobos-Puc, LE; González-Hernández, A; Lozano-Cuenca, J; Muñoz-Islas, E; Pertz, HH; Sánchez-López, A; Villalón, CM | 1 |
| Johnson, ZB; Looper, ML; Rorie, RW; Rosenkrans, CF; Wang, H | 1 |
| Altamirano-Espinoza, AH; González-Hernández, A; MaassenVanDenBrink, A; Manrique-Maldonado, G; Marichal-Cancino, BA; Ruiz-Salinas, II; Villalón, CM | 1 |
4 trial(s) available for dihydroergotamine and yohimbine
| Article | Year |
|---|---|
[Conservative treatment of peripheral arterial occlusive diseases].
Topics: Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Vasodilator Agents; Yohimbine | 1978 |
[Diagnosis and therapy of Raynaud's phenomenon (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Female; Fingers; Humans; Male; Middle Aged; Plethysmography, Impedance; Raynaud Disease; Yohimbine | 1975 |
[Clinical treatment of peripheral arterial occlusive diseases].
Topics: Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Drug Evaluation; Ergoloid Mesylates; Ergotamines; Female; Hemodynamics; Humans; Male; Middle Aged; Yohimbine | 1976 |
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Exercise Test; Flunarizine; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Placebos; Pyrrolidines; Secologanin Tryptamine Alkaloids; Yohimbine | 1985 |
25 other study(ies) available for dihydroergotamine and yohimbine
| Article | Year |
|---|---|
Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
Topics: Amino Acid Sequence; Base Sequence; Cloning, Molecular; Cyclic AMP; GTP-Binding Proteins; Humans; Molecular Sequence Data; Pertussis Toxin; Receptors, Serotonin; Virulence Factors, Bordetella | 1991 |
Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood Pressure; Brain; Cell Membrane; Clonidine; Kinetics; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Vasoconstriction | 1984 |
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
Topics: Adenylyl Cyclases; Base Sequence; Cloning, Molecular; DNA Primers; Humans; Molecular Sequence Data; Receptors, Serotonin; Sequence Alignment; Sequence Homology, Amino Acid; Serotonin Antagonists; Serotonin Receptor Agonists; Signal Transduction | 1993 |
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorders; Propylamines; Protein Binding; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents | 1996 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Therapy of chronic arterial occlusive disease. Studies with an orally administered drug under ambulatory conditions].
Topics: Adult; Aged; Arterial Occlusive Diseases; Diabetes Complications; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Drug Evaluation; Ergotamines; Female; Gangrene; Humans; Intermittent Claudication; Leg Ulcer; Male; Middle Aged; Pulse; Yohimbine | 1977 |
[Management of poorly healing leg ulcers].
Topics: Aged; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Female; Humans; Leg Ulcer; Wound Healing; Yohimbine | 1975 |
[Vasodilator substances and their effect on the pia mater arteries. Study by means of magnetographic measurements].
Topics: Animals; Dihydroergotamine; Dihydroergotoxine; Pia Mater; Rabbits; Vasodilator Agents; Yohimbine | 1976 |
Role of adrenoceptors in vitro and in vivo in the effects of lithium on blood glucose levels and insulin secretion in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Dihydroergotamine; Glucose Tolerance Test; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Lithium; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Sympatholytics; Yohimbine | 1990 |
Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.
Topics: Administration, Oral; Animals; Dihydroergotamine; Dihydroergotoxine; Dogs; Drug Interactions; Electric Stimulation; Female; Injections, Intravenous; Male; Methiothepin; Muscle, Smooth, Vascular; Norepinephrine; Receptors, Serotonin; Vasoconstriction; Yohimbine | 1990 |
Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
Topics: Administration, Oral; Animals; Dihydroergotamine; Dogs; Injections, Intravenous; Norepinephrine; Pizotyline; Serotonin; Vasoconstriction; Veins; Yohimbine | 1987 |
Receptors involved in the nervous system regulation of polyamine metabolism in rat salivary glands.
Topics: Animals; Atropine; Dihydroergotamine; Male; Ornithine Decarboxylase; Parasympathetic Nervous System; Phentolamine; Propranolol; Putrescine; Rats; Rats, Inbred Strains; Salivary Glands; Spermidine; Spermine; Sympathetic Nervous System; Yohimbine | 1989 |
[Therapy of organic psychosyndromes of cerebrovascular origin with a vasoactive drug combination].
Topics: Adult; Aged; Cerebrovascular Disorders; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Humans; Middle Aged; Neurocognitive Disorders; Psychological Tests; Secologanin Tryptamine Alkaloids; Self-Assessment; Yohimbine | 1985 |
Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.
Topics: Cocaine; Dihydroergotamine; Humans; In Vitro Techniques; Norepinephrine; Pizotyline; Prazosin; Receptors, Adrenergic, alpha; Receptors, Serotonin; Saphenous Vein; Vasoconstriction; Yohimbine | 1984 |
The influence of drugs on disseminated intravascular coagulation (DIC). V. Effects of alpha-adrenoceptor blocking agents on thrombin-induced DIC in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Dibenzylchlorethamine; Dihydroergotamine; Disseminated Intravascular Coagulation; Male; Oxygen Consumption; Rats; Rats, Inbred Strains; Thrombin; Thrombosis; Yohimbine | 1981 |
Alpha 2-adrenoceptors modulating insulin release from isolated pancreatic islets.
Topics: Animals; Dihydroergotamine; Epinephrine; In Vitro Techniques; Insulin; Islets of Langerhans; Male; Phenoxybenzamine; Phentolamine; Prazosin; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Yohimbine | 1980 |
Pharmacokinetics of a combination of raubasine, dihydroergocristine and dihydroergotamine in dogs and human beings.
Topics: Animals; Bile; Dihydroergotamine; Dihydroergotoxine; Dogs; Drug Combinations; Humans; Isomerism; Kinetics; Protein Binding; Secologanin Tryptamine Alkaloids; Tissue Distribution; Yohimbine | 1981 |
Ex vivo studies after oral treatment of the beagle with dihydroergotamine.
Topics: Animals; Dihydroergotamine; Dogs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Serotonin; Time Factors; Vasoconstrictor Agents; Veins; Yohimbine | 1983 |
Orthostatic hypotension.
Topics: Cerebrovascular Circulation; Clonidine; Deamino Arginine Vasopressin; Dihydroergotamine; Dopamine; Epinephrine; Humans; Hypotension, Orthostatic; Metoclopramide; Octreotide; Patient Education as Topic; Pindolol; Yohimbine | 1994 |
Blockade of noradrenaline-induced constrictions by yohimbine and prazosin differs between consecutive segments of cutaneous arteries in guinea-pig ears.
Topics: Animals; Arteries; Dihydroergotamine; Ear, External; Female; Guinea Pigs; In Vitro Techniques; Ketanserin; Male; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Regional Blood Flow; Serotonin; Vasoconstriction; Yohimbine | 1994 |
Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.
Topics: Adrenergic alpha-Antagonists; Animals; Dihydroergotamine; Dinoprost; Endothelium, Vascular; Ergotamine; Humans; In Vitro Techniques; Muscle Relaxation; Pulmonary Artery; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swine; Vasoconstrictor Agents; Yohimbine | 1996 |
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine | 1999 |
Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Pressure; Decerebrate State; Dihydroergotamine; Dose-Response Relationship, Drug; Drug Combinations; Electric Stimulation; Heart Rate; Hemodynamics; Male; Methysergide; Norepinephrine; Oxadiazoles; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic, alpha-2; Serotonin Antagonists; Sympathetic Nervous System; Tachycardia; Yohimbine | 2009 |
Involvement of signaling pathways in bovine sperm motility, and effect of ergot alkaloids.
Topics: Animals; Cattle; Chelating Agents; Cholera Toxin; Cyclic AMP; Dihydroergotamine; Egtazic Acid; Ergot Alkaloids; Ergotamine; Male; Pertussis Toxin; Prazosin; Receptors, Adrenergic, alpha; Signal Transduction; Sperm Motility; Spermatozoa; Yohimbine | 2009 |
Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors.
Topics: Acetylcholine; Animals; Blood Circulation; Calcitonin Gene-Related Peptide; Capsaicin; Carotid Arteries; Dihydroergotamine; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Injections, Spinal; Male; Oxadiazoles; Piperazines; Propylene Glycol; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Antagonists; Vasodilation; Vasodilator Agents; Yohimbine | 2012 |